ENTITY
SillaJen Inc

SillaJen Inc (215600 KS)

52
Analysis
Health Care • South Korea
SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.
more
bullish•SillaJen Inc
•03 Nov 2016 11:26

SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level

* In Part 2 (as below), I summarized the growth potential and appropriate valuation level of SillaJen.Apparently, not many people are doubtful...

Logo
406 Views
Share
bullish•SillaJen Inc
•02 Nov 2016 15:20

SillaJen IPO Part 1 - Schedule, Financials & Valuation

SillaJen Biotherapeutics (established in 2006) submitted the IPO report. The company develops potent multi-functional immunotherapeutics for...

Logo
525 Views
Share
x